Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve (scientific article published in January 2014)

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial

Q24656644

Use and abuse of HOMA modeling

Q28263292

GLP-1 for type 2 diabetes

Q33794098

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Q34617065

Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies

Q35649213

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

Q35797022

Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release

Q36989349

Glucose memory of pancreatic B and A2 cells: evidence for common time-dependent actions of glucose on insulin and glucagon secretion in the perfused rat pancreas

Q37041187

Functional assessment of pancreatic beta-cell area in humans

Q37236300

Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas

Q42489582

Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus

Q42516146

The stunned beta cell: a brief history

Q43073326

Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes

Q43194107

Consequences on beta-cell function and reserve after long-term pancreas transplantation

Q44779243

AIRarg and AIRgluc as predictors of insulin secretory reserve

Q44934266

Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people

Q46827195

Acute insulin responses to glucose and arginine as predictors of beta-cell secretory capacity in human islet transplantation

Q46874124

Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine

Q47755819

Effects of duration of type 2 diabetes mellitus on insulin secretion

Q51491083

Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).

Q51537986

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

Q51671449

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

type 2 diabetes

Q3025883

P304

page(s)

39-48

P577

publication date

2014-01-01

P1433

published in

Journal of Internal Medicine

Q6295387

P1476

title

Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve

P478

volume

275

Reverse relations

cites work (P2860)

Q35603376	Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets
Q36597841	Intermittent neonatal hypoxia elicits the upregulation of inflammatory-related genes in adult male rats through long-lasting programming effects
Q89170110	PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients
Q92947512	Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery
Q61861508	The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors